MedPlus Health Services has announced the schedule for its earnings call with analysts and institutional investors, pertaining to the audited financial results for the quarter and financial year ended March 31, 2026. The intimation has been made pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement was communicated to both BSE Limited and the National Stock Exchange of India Limited on May 11, 2026.

Earnings Call Schedule

The earnings call is set to be hosted by the company. The key details of the event are as follows:

How to Join the Earnings Call

Participants have two options to join the earnings call. The joining details are outlined below.

Option 1: Pre-Registration

Investors and analysts may pre-register using the dedicated link to join the call without waiting for an operator:

• Pre-registration link: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=3786667&linkSecurityString=1f382422c6

Option 2: Dial-In

Participants using dial-in numbers are advised to connect at least 10 minutes prior to the scheduled start time. The dial-in details are as follows:

Availability of Information

The earnings call details and related information will be made available on the company's official website at www.medplusindia.com , as well as on the websites of BSE Limited ( www.bseindia.com ) and the National Stock Exchange of India Limited ( www.nseindia.com ). The intimation has been signed by Manoj Kumar Srivastava, Company Secretary & Compliance Officer, MedPlus Health Services.

MedPlus Health Services Limited has disclosed that its subsidiary, Optival Health Solutions Private Limited, has received a drug license suspension order for one of its stores in Chhattisgarh. The disclosure was made pursuant to Regulation 30 read with Para A, Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in accordance with relevant SEBI circulars.

Drug License Suspension Order Details

The suspension order was issued by the Assistant Drugs Controller, Durg District, Chhattisgarh, targeting the store situated at Santrabadi Durg, Chhattisgarh. The order was received on May 05, 2026, and mandates a suspension of the drug license for a period of sixty-five days. The action has been initiated under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945.

The following table summarises the key details of the regulatory action as disclosed by the company:

Financial and Operational Impact

The company has quantified the potential financial impact of this suspension at Rs 16.00 lacs in revenue loss. The affected store is operated by Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services. The disclosure was signed by Manoj Kumar Srivastava, Company Secretary & Compliance Officer, on May 06, 2026.

The regulatory filing is available on the company's website at www.medplusindia.com , as well as on the websites of BSE Limited and National Stock Exchange of India Limited.